220 related articles for article (PubMed ID: 29029605)
1. Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes.
Iaccino E; Mimmi S; Dattilo V; Marino F; Candeloro P; Di Loria A; Marimpietri D; Pisano A; Albano F; Vecchio E; Ceglia S; Golino G; Lupia A; Fiume G; Quinto I; Scala G
Mol Cancer; 2017 Oct; 16(1):159. PubMed ID: 29029605
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects.
Titzer S; Christensen O; Manzke O; Tesch H; Wolf J; Emmerich B; Carsten C; Diehl V; Bohlen H
Br J Haematol; 2000 Mar; 108(4):805-16. PubMed ID: 10792287
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.
Wang J; Hendrix A; Hernot S; Lemaire M; De Bruyne E; Van Valckenborgh E; Lahoutte T; De Wever O; Vanderkerken K; Menu E
Blood; 2014 Jul; 124(4):555-66. PubMed ID: 24928860
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
Dembic Z; Schenck K; Bogen B
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
[TBL] [Abstract][Full Text] [Related]
5. Tumor cell heterogeneity in multiple myeloma: antigenic, morphologic, and functional studies of cells from blood and bone marrow.
King MA; Nelson DS
Blood; 1989 May; 73(7):1925-35. PubMed ID: 2785420
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific recognition of human myeloma cells by idiotype-induced CD8(+) T cells.
Li Y; Bendandi M; Deng Y; Dunbar C; Munshi N; Jagannath S; Kwak LW; Lyerly HK
Blood; 2000 Oct; 96(8):2828-33. PubMed ID: 11023518
[TBL] [Abstract][Full Text] [Related]
7. Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells.
Wen YJ; Barlogie B; Yi Q
Blood; 2001 Mar; 97(6):1750-5. PubMed ID: 11238117
[TBL] [Abstract][Full Text] [Related]
8. In vitro priming of myeloma antigen-specific allogeneic donor T cells with idiotype pulsed dendritic cells.
Kim SB; Baskar S; Kwak LW
Leuk Lymphoma; 2003 Jul; 44(7):1201-8. PubMed ID: 12916873
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal anti-idiotype antibodies against the murine B cell lymphoma 38C13: characterization and use as probes for the biology of the tumor in vivo and in vitro.
Maloney DG; Kaminski MS; Burowski D; Haimovich J; Levy R
Hybridoma; 1985; 4(3):191-209. PubMed ID: 3899906
[TBL] [Abstract][Full Text] [Related]
10. Characterization of CLL exosomes reveals a distinct microRNA signature and enhanced secretion by activation of BCR signaling.
Yeh YY; Ozer HG; Lehman AM; Maddocks K; Yu L; Johnson AJ; Byrd JC
Blood; 2015 May; 125(21):3297-305. PubMed ID: 25833959
[TBL] [Abstract][Full Text] [Related]
11. Membrane-bound HSP70-engineered myeloma cell-derived exosomes stimulate more efficient CD8(+) CTL- and NK-mediated antitumour immunity than exosomes released from heat-shocked tumour cells expressing cytoplasmic HSP70.
Xie Y; Bai O; Zhang H; Yuan J; Zong S; Chibbar R; Slattery K; Qureshi M; Wei Y; Deng Y; Xiang J
J Cell Mol Med; 2010 Nov; 14(11):2655-66. PubMed ID: 19627400
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
[TBL] [Abstract][Full Text] [Related]
13. Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy.
Massaia M; Borrione P; Battaglio S; Mariani S; Beggiato E; Napoli P; Voena C; Bianchi A; Coscia M; Besostri B; Peola S; Stiefel T; Even J; Novero D; Boccadoro M; Pileri A
Blood; 1999 Jul; 94(2):673-83. PubMed ID: 10397734
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
Xie Y; Bai O; Zhang H; Li W; Xiang J
Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
[TBL] [Abstract][Full Text] [Related]
15. Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
Curti A; Tosi P; Comoli P; Terragna C; Ferri E; Cellini C; Massaia M; D'Addio A; Giudice V; Di Bello C; Cavo M; Conte R; Gugliotta G; Baccarani M; Lemoli RM
Br J Haematol; 2007 Nov; 139(3):415-24. PubMed ID: 17910631
[TBL] [Abstract][Full Text] [Related]
16. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.
Clayton A; Court J; Navabi H; Adams M; Mason MD; Hobot JA; Newman GR; Jasani B
J Immunol Methods; 2001 Jan; 247(1-2):163-74. PubMed ID: 11150547
[TBL] [Abstract][Full Text] [Related]
17. Specific detection of myeloma plasma cells using anti-idiotypic single chain antibody fragments selected from a phage display library.
Willems PM; Hoet RM; Huys EL; Raats JM; Mensink EJ; Raymakers RA
Leukemia; 1998 Aug; 12(8):1295-302. PubMed ID: 9697887
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition of myeloma cells by anti-idiotype antibodies in the absence of membrane-bound immunoglobulin.
Moshitzky S; Kukulansky T; Haimovich J; Hollander N
Immunol Cell Biol; 2008; 86(3):261-7. PubMed ID: 18195726
[TBL] [Abstract][Full Text] [Related]
19. Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
Macarrón Palacios A; Grzeschik J; Deweid L; Krah S; Zielonka S; Rösner T; Peipp M; Valerius T; Kolmar H
Front Immunol; 2020; 11():560244. PubMed ID: 33324393
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation of IgG B cell receptor (IgG BCR) in multiple myeloma: relationship between sialylation and the signal activity of IgG BCR.
Ilić V; Milosević-Jovcić N; Petrović S; Marković D; Stefanović G; Ristić T
Glycoconj J; 2008 May; 25(4):383-92. PubMed ID: 18188696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
